Adoption of minimally invasive techniques, technological advancements, substantial prevalence of rhinosinusitis with favorable reimbursement scenarios are forecasted to fuel the market growth
Vancouver, BC -- (SBWIRE) -- 02/03/2021 -- Chronic Rhinosinusitis Market
The chronic rhinosinusitis market is set to attain a valuation of USD 3,508.0 million by 2027, registering a CAGR of 7.4%. Chronic rhinosinusitis is an inflammatory disorder of the sinuses that persists for 12 weeks or longer. It can occur due to infection, abnormal growths in sinuses, or swelling in the sinuses' linings. Increasing incidences of chronic asthma and inflammation of sinuses' mucosal linings are driving the market growth.
Get your FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.emergenresearch.com/request-sample/74
Leading Players Profiled in the Report Include:
AstraZeneca, Bayer AG, Ivax Pharmaceuticals, Pfizer, Novartis Pharmaceuticals Corporation, Sanofi, Sunovion Pharmaceuticals, Cipla, Smith & Nephew, Medtronic, SinuSys Corporation, Olympus Corporation and Acclarent among other companies
Market Drivers
The major driving forces for the development of the chronic rhinosinusitis market are the rising incidences of inflammation of mucosal linings of the nasal passage, increasing prevalence of paranasal sinuses, and cases of chronic asthma.
Moreover, widespread awareness among people regarding the target disease symptoms and technological progressions can enhance the industry's growth during the forecast period.
Product Outlook (Revenue in Million USD; 2017–2027)
Steroids
Topical Nasal Steroid
Systemic Steroids
Nasal Irrigation
Hypertonic and Isotonic Saline
Steroid Nasal Irrigation
Topical Antibiotic Therapy
Surgical Based
Ethmoidectomy
Endoscopic Intranasal Intervention
Others
Antibiotics
Amoxicillin-Clavulanate
Clindamycin
Sulfamethoxazole
Levofloxacin
Macrolide Therapy
Antifungal Therapy
Disease Outlook (Revenue in Million USD; 2017–2027)
Anatomical Differences
Nasal Tumors
Mucosal Edema
Non-Allergic Rhinitis
Immune Deficiency
Other
Distribution Channel (Revenue in Million USD; 2017–2027)
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Other
ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.emergenresearch.com/select-license/74
The following are the main reasons to buy the Global Chronic Rhinosinusitis Market report:
The latest report closely evaluates the overall market size and infers on various aspects, such as the current business trends, market share, product offerings, and product share.
It offers a detailed account of the end-use applications of the products & services offered by this industry.
It offers an insightful analysis of the various regional segments of the market that are projected to witness enormous growth over the forecast period.
Furthermore, the report covers the latest developments taking place in the market and effective business strategies implemented by the leading market rivals.
The report considers the following market growth estimation timeline:
Historical Years: 2017-2018
Base Year: 2019
Estimated Year: 2027
Forecast Years: 2020-2027
Regional Analysis
In 2019, the Asia Pacific region accounted for 8.3% market share in terms of revenue. This is due to rising incidences of rhinosinusitis and chronic asthma in the region. Moreover, due to growingpollution levels, excessive smoking and environmental concerns are leading drivers of market growth in this region, especially in developing countries like India and China.
In 2019, the North America region held the largest market sharedue to advanced technology and noteworthy advancements in treatment techniques, andsupportive reimbursement policies and investment opportunities.The prevalence of rhinosinusitis and chronic rhinosinusitisin the United States ranges from 1% to 5% of the total population, that is, approximately 15 million people. Thus, the increasing incidence of the target disease is expected to drive the region's chronic rhinosinusitis market.
Take a Look at our Related Reports:
Activated Carbon Market Development Strategy
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Future Growth
Neurostimulation Devices Market Research Methodology
Signal Intelligence (SIGINT) Market Drivers
Sodium Dichromate Market Manufacturers
Industrial Microbiology Market Revenue
Surgical Instrument Tracking Systems Market Size
Medical Lighting Technologies Market Share
Smart Irrigation Controllers Market Trends
Soldier System Market Growth
Plant-Based Food & Beverage Alternatives Market Analysis
Nano Drones Market Business Opportunities
Fermented Food and Ingredients Market Key Players
Mobile Robot Market Demand
Forensic Technology Market Competitive Landscape
Autonomous Delivery Vehicles Market Segments
Solid Waste Management Market Overview
Prenatal Testing Industry
Digital Biomarkers Market Statistics
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/press-release/global-chronic-rhinosinusitis-market